Mar 3, 2026 05:31PM
Feb 16, 2026 05:31PM
Feb 3, 2026 04:01PM
Dec 22, 2025 07:06AM
Dec 21, 2025 08:00PM
Dec 11, 2025 06:10PM
Dec 11, 2025 06:09PM FDA APPROVES UPLIZNA® FOR ADULTS WITH GENERALIZED MYASTHENIA GRAVIS
Dec 4, 2025 08:30AM
Nov 19, 2025 04:02PM
Nov 19, 2025 04:01PM
Nov 8, 2025 10:15AM
Nov 8, 2025 10:15AM
Nov 4, 2025 04:01PM
Oct 31, 2025 09:00AM AMGEN to present Repatha trial data at heart association meeting
Oct 31, 2025 09:00AM
Oct 17, 2025 04:11PM
Oct 17, 2025 04:00PM
Oct 17, 2025 04:00PM
Oct 2, 2025 09:00AM
Oct 2, 2025 09:00AM
Oct 1, 2025 01:20PM Canaccord #1 Key Risk to AxoGen, Inc. (AXGN): 'the FDA running out of carryover funding and needing to halt work'
Oct 1, 2025 01:13PM
Sep 10, 2025 09:16AM
Sep 9, 2025 12:13AM
Sep 9, 2025 12:12AM
Sep 8, 2025 08:04PM
Sep 8, 2025 08:04PM
Aug 25, 2025 09:03AM FDA expands AMGEN's Repatha approval for cardiovascular risk reduction
Aug 25, 2025 09:00AM
Aug 5, 2025 04:01PM
Jul 21, 2025 07:00AM
Jul 21, 2025 07:00AM
Jun 30, 2025 09:01AM
Jun 30, 2025 09:00AM
Jun 23, 2025 02:31PM Amgen (AMGN) reports full results from Part 1 of the Phase 2 study of MariTide
Jun 23, 2025 02:31PM
Jun 18, 2025 09:00AM
Jun 2, 2025 08:04AM
May 15, 2025 02:04PM
May 1, 2025 04:22PM
May 1, 2025 04:01PM
Apr 12, 2025 04:00AM Biotech sector Q1 earnings preview from RBC Capital Markets
Apr 11, 2025 09:02AM
Apr 11, 2025 09:00AM
Apr 4, 2025 08:10AM
Apr 3, 2025 04:00PM
Apr 3, 2025 03:36PM
Apr 3, 2025 03:35PM
Apr 3, 2025 03:27PM US FDA approves Amgen's Uplizna as first treatment for rare immune disorder
Apr 3, 2025 02:51PM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All